Carl Zeiss Meditec AG
XETRA:AFX
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
54.65
121.95
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one AFX stock under the Base Case scenario is 100.24 EUR. Compared to the current market price of 55.45 EUR, Carl Zeiss Meditec AG is Undervalued by 45%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Carl Zeiss Meditec AG
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for AFX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Carl Zeiss Meditec AG
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Carl Zeiss Meditec AG
Balance Sheet Decomposition
Carl Zeiss Meditec AG
Current Assets | 1.8B |
Cash & Short-Term Investments | 33.8m |
Receivables | 1.2B |
Other Current Assets | 593.7m |
Non-Current Assets | 1.1B |
Long-Term Investments | 14m |
PP&E | 332.6m |
Intangibles | 684.5m |
Other Non-Current Assets | 110.5m |
Current Liabilities | 507.4m |
Accounts Payable | 186.7m |
Accrued Liabilities | 116.1m |
Other Current Liabilities | 204.7m |
Non-Current Liabilities | 318.5m |
Long-Term Debt | 217m |
Other Non-Current Liabilities | 101.5m |
Earnings Waterfall
Carl Zeiss Meditec AG
Revenue
|
2.1B
EUR
|
Cost of Revenue
|
-927.4m
EUR
|
Gross Profit
|
1.1B
EUR
|
Operating Expenses
|
-872.9m
EUR
|
Operating Income
|
265.8m
EUR
|
Other Expenses
|
-62.6m
EUR
|
Net Income
|
203.2m
EUR
|
Free Cash Flow Analysis
Carl Zeiss Meditec AG
EUR | |
Free Cash Flow | EUR |
Carl Zeiss Meditec reported a slight revenue decline of 1.5% to EUR 1.487 billion for the first nine months of fiscal year 2023-24, impacted by adverse currency effects. EBIT fell by 34% to EUR 163 million, with a margin of 10.9%, largely due to reduced revenue and a weaker product mix. Despite tough market conditions, especially in North America, there are signs of stabilization in order intake. The company expects DORC to contribute EUR 100 million in revenue in the second half. Zeiss maintains a revenue target of EUR 2 billion and an adjusted EBIT range of EUR 225-275 million, focusing on strict cost control measures to mitigate economic challenges.
What is Earnings Call?
AFX Profitability Score
Profitability Due Diligence
Carl Zeiss Meditec AG's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Carl Zeiss Meditec AG's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
AFX Solvency Score
Solvency Due Diligence
Carl Zeiss Meditec AG's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Score
Carl Zeiss Meditec AG's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AFX Price Targets Summary
Carl Zeiss Meditec AG
According to Wall Street analysts, the average 1-year price target for AFX is 72.6 EUR with a low forecast of 54.54 EUR and a high forecast of 109.2 EUR.
Dividends
Current shareholder yield for AFX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 3,531 full-time employees. The company went IPO on 2000-03-20. The company offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The firm has various production sites in Europe, the United States and Asia.
Contact
IPO
Employees
Officers
The intrinsic value of one AFX stock under the Base Case scenario is 100.24 EUR.
Compared to the current market price of 55.45 EUR, Carl Zeiss Meditec AG is Undervalued by 45%.